ALPROLIX®: the first EHL FIX
WITH >10 years OF REAL-WORLD EXPERIENCE1–3
Click to Explore the BODY of ALPROLIX evidence
USA flag icon Canada flag icon Multi-centre qualitative survey UK flag icon SHL switch Europe flag icon European chart review Whole-country switch Ireland flag icon Previous FIX switch France flag icon
Scalpel icon Surgery Syringe icon On-demand to prophylaxis

References

  1. ALPROLIX Package Insert. FDA.
    Revised May 2023.
  2. Rebinyn Package Insert. FDA. Revised August 2022.
  3. Idelvion Package Insert. FDA. Revised June 2023.
  4. Malec LM, et al. ASH 2019 Abstract 2407.
  5. Wall C, et al. UKHCDO poster presented at EAHAD 2020.
  6. O'Donovan M, et al. Haemophilia. 2021;27(4):618–625.
  7. O’Donovan M, et al. Res Pract Thromb Haemost. 2021;5:e12602.
  1. Chambost H, et al. Ther Adv Hematol. 2025:16;1–15.
  2. Funding E, et al. Adv Ther. 2023;40(9):3770–3783.
  3. O’Donovan M, et al. Haemophilia.
    2021;27(6):e690–e697.
  4. Shapiro A, et al. Haemophilia. 2020;26(6):975–983.
  5. ALPROLIX UK Summary of Product Characteristics.
  6. ALPROLIX EU Summary of Product Characteristics.




Back Safety information References
Multi-centre qualitative survey SHL switch European chart review Whole-country switch Previous FIX switch Surgery On-demand to prophylaxis